Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
about
Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemiaPathophysiologic therapeutic targets in hypertension: a cardiological point of view.Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
P2860
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@en
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@nl
type
label
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@en
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@nl
prefLabel
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@en
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@nl
P2093
P2860
P1476
Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.
@en
P2093
Carvalho AC
Fonseca FA
Kasinski N
P2860
P304
P356
10.1046/J.1440-1681.2003.03911.X
P577
2003-10-01T00:00:00Z